Rapid Therapeutic Science Laboratories, Inc.
company.status.inactiveCIK 1575659fmd_1TD6J2A2RJCE1AGJ05NBQKKSS1Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2014 to Jun 30, 2023, 35 periods
Latest annual · FY2022
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (0)
- Net income
- (2)
- Free cash flow
- (1)
Latest quarter · Q2 FY2023
Millions- Total revenues
- 0
- Gross profit
- 0
- Net income
- 0
- Free cash flow
- (0)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2019 to FY2022
- n/m
- Revenue, 5 yearsFY2017 to FY2022
- n/m
- Net income, 5 yearsFY2017 to FY2022
- n/m
Rapid Therapeutic Science Laboratories, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2022 | FY2021 | Change | Source |
|---|---|---|---|---|
| Revenue | $0 | $534 | -100% | 10-K 2023-03-30 · proof |
| Gross profit | $0 | $334 | -100% | 10-K 2023-03-30 · proof |
| Net income | -$1.8 million | -$2.9 million | 10-K 2023-03-30 · proof | |
| Cash from operating activities | -$1.2 million | -$2.2 million | 10-K 2023-03-30 · proof | |
| Free cash flow | -$1.2 million | -$2.5 million | 10-K 2023-03-30 · proof | |
| Total assets | $2.3 million | $2.2 million | +2.5% | 10-K 2023-03-30 · proof |
| Total liabilities | $5.4 million | $3.6 million | +50.7% | 10-K 2023-03-30 · proof |
| Cash and cash equivalents | $0 | $192,484 | -100% | 10-K 2023-03-30 · proof |
- What was Rapid Therapeutic Science Laboratories, Inc.'s revenue in fiscal 2022?
- Rapid Therapeutic Science Laboratories, Inc. reported revenue of $0 for fiscal 2022 (the year ended Dec 31, 2022), against $534 the year before (-100%). Source: the 10-K filed with the SEC on Mar 30, 2023. SEC
- What was Rapid Therapeutic Science Laboratories, Inc.'s gross profit in fiscal 2022?
- Rapid Therapeutic Science Laboratories, Inc. reported gross profit of $0 for fiscal 2022 (the year ended Dec 31, 2022), against $334 the year before (-100%). Source: the 10-K filed with the SEC on Mar 30, 2023. SEC
- What was Rapid Therapeutic Science Laboratories, Inc.'s net income in fiscal 2022?
- Rapid Therapeutic Science Laboratories, Inc. reported net income of -$1.8 million for fiscal 2022 (the year ended Dec 31, 2022), against -$2.9 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2023. SEC
- What was Rapid Therapeutic Science Laboratories, Inc.'s cash from operating activities in fiscal 2022?
- Rapid Therapeutic Science Laboratories, Inc. reported cash from operating activities of -$1.2 million for fiscal 2022 (the year ended Dec 31, 2022), against -$2.2 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2023. SEC
- What was Rapid Therapeutic Science Laboratories, Inc.'s free cash flow in fiscal 2022?
- Rapid Therapeutic Science Laboratories, Inc. reported free cash flow of -$1.2 million for fiscal 2022 (the year ended Dec 31, 2022), against -$2.5 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2023. SEC
- What are Rapid Therapeutic Science Laboratories, Inc.'s total assets?
- As of Dec 31, 2022, Rapid Therapeutic Science Laboratories, Inc. reported total assets of $2.3 million, against $2.2 million a year earlier (+2.5%). Source: the 10-K filed with the SEC on Mar 30, 2023. SEC
- What are Rapid Therapeutic Science Laboratories, Inc.'s total liabilities?
- As of Dec 31, 2022, Rapid Therapeutic Science Laboratories, Inc. reported total liabilities of $5.4 million, against $3.6 million a year earlier (+50.7%). Source: the 10-K filed with the SEC on Mar 30, 2023. SEC
- What are Rapid Therapeutic Science Laboratories, Inc.'s cash and cash equivalents?
- As of Dec 31, 2022, Rapid Therapeutic Science Laboratories, Inc. reported cash and cash equivalents of $0, against $192,484 a year earlier (-100%). Source: the 10-K filed with the SEC on Mar 30, 2023. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1575659&period_type=annual&limit=5"Information only, not investment advice.